A close look at the hormone leptin has revealed a link between methylation of the leptin gene and the development of male infants. The study was led by associate professor Carmen Marsit and graduate student Corina Lesseur.
Dr. Glyn Elwyn of the Dartmouth Center for Health Care Delivery Science is the principal investigator of a study on the use of two methods—shared decision-making and motivational interviewing—when discussing options for treatment with patients.
Using next generation DNA sequencing, Dartmouth scientists have identified potentially actionable mutations in cancers of the appendix. When specific mutations for a cancer type are identified, patients can be treated with chemotherapy or other targeted agents that work on those mutations.
Tor D. Tosteson, Sc.D., a Geisel professor of community and family medicine and of The Dartmouth Institute of Health Policy and Clinical Practice, has been selected as a Fellow of the American Statistical Association.
Dartmouth will serve as a Lead Academic Participating Site in the National Cancer Institute’s (NCI) new National Clinical Trials Network (NCTN), which is intended to improve the speed and efficiency of conducting cancer clinical trials.
Dartmouth researchers have found that the anxiety experienced with a false-positive mammogram is temporary and does not negatively impact a woman’s overall well-being.
Using CT scans with contrast enhancement, Dartmouth researchers measured treatment response to pancreatic cancerphotodynamic therapy (PDT) according to a paper published in Physics in Medicine and Biology.
Fast food giants attempts at depicting healthier kids’ meals frequently goes unnoticed by children ages 3 to 7 years old according to a new study by Dartmouth-Hitchcock Norris Cotton Cancer Center.
Dartmouth researchers at its Norris Cotton Cancer Center have compiled a review of the role that information gathered through genetic testing plays in the diagnosis and treatment of breast cancer.
Dartmouth’s Geisel School of Medicine and Aeras, a global nonprofit biotech, announced a collaboration to jointly conduct a trial of a new vaccine against tuberculosis (TB), one of the world’s deadliest diseases.